333 related articles for article (PubMed ID: 10870121)
1. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M
Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
[TBL] [Abstract][Full Text] [Related]
2. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M
Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid antibodies in pediatric systemic lupus erythematosus.
Seaman DE; Londino AV; Kwoh CK; Medsger TA; Manzi S
Pediatrics; 1995 Dec; 96(6):1040-5. PubMed ID: 7491218
[TBL] [Abstract][Full Text] [Related]
4. [Vasculopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome].
Alekberova ZS; Reshetniak TM; Rodenska-Lopovok SG; Aleksandrova EN; Kalashnikova LA; Nasonov EL; Mach ES; Nasonova VA
Ter Arkh; 1995; 67(5):41-4. PubMed ID: 7638777
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of vascular occlusive disease associated with antiphospholipid syndromes.
Bacharach JM; Lie JT; Homburger HA
Int Angiol; 1992; 11(1):51-6. PubMed ID: 1522353
[TBL] [Abstract][Full Text] [Related]
6. [The prediction of thrombosis development in patients with systemic lupus erythematosus: the role of antibodies to cardiolipin].
Nasonov EL; Kovalev VIu; Alekberova ZS; Solov'ev SK
Ter Arkh; 1992; 64(5):25-30. PubMed ID: 1455369
[TBL] [Abstract][Full Text] [Related]
7. [Anticardiolipin antibodies in systemic lupus erythematosus: prevalence and clinical associations].
Abumohor P; Cerda C; Neira O; Palma S; Alvarado MA; Basualdo J; Bravo M; Guzmán L
Rev Med Chil; 1991 May; 119(5):517-23. PubMed ID: 1844289
[TBL] [Abstract][Full Text] [Related]
8. A family study of the antiphospholipid syndrome associated with other autoimmune diseases.
Dagenais P; Urowitz MB; Gladman DD; Norman CS
J Rheumatol; 1992 Sep; 19(9):1393-6. PubMed ID: 1433007
[TBL] [Abstract][Full Text] [Related]
9. [Importance of antiphosphatidylserine antibodies in patients with lupus anticoagulant. Analysis of 30 cases].
Zuazu-Jausoro I; Oliver A; Monserrat I; Borrell M; Garí M; Pich I; Grau E; Fontcuberta J
Med Clin (Barc); 1990 Jul; 95(6):210-3. PubMed ID: 2123507
[TBL] [Abstract][Full Text] [Related]
10. Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus.
Vianna JL; Haga HJ; Tripathi P; Cervera R; Khamashta MA; Hughes GR
Ann Rheum Dis; 1992 Feb; 51(2):160-1. PubMed ID: 1550396
[TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibodies: risk factors or only markers for thrombosis, fetal loss and thrombocytopenia?
Out HJ; Kater L; Derksen RH
Neth J Med; 1990 Apr; 36(3-4):177-81. PubMed ID: 2355994
[No Abstract] [Full Text] [Related]
12. [The heterogeneity of systemic lupus erythematosus due to the antiphospholipid syndrome].
Alekberova ZS; Nasonov EL; Stoianovich LZ
Ter Arkh; 1992; 64(5):77-9. PubMed ID: 1455383
[No Abstract] [Full Text] [Related]
13. Abrogation of experimental systemic lupus erythematosus and primary antiphospholipid syndrome with intravenous gamma globulin.
Krause I; Blank M; Kopolovic J; Afek A; Goldberg I; Tomer Y; Shoenfeld Y
J Rheumatol; 1995 Jun; 22(6):1068-74. PubMed ID: 7545755
[TBL] [Abstract][Full Text] [Related]
14. [Anti-endothelial cell antibodies in systemic lupus erythematosus: association with vascular and renal lesions].
Cervera R; Khamashta MA; Font J; López-Soto A; D'Cruz D; Navarro M; Hughes GR; Ingelmo M; Urbano-Márquez A
Med Clin (Barc); 1992 Nov; 99(16):605-8. PubMed ID: 1460923
[TBL] [Abstract][Full Text] [Related]
15. Primary antiphospholipid syndrome.
Alarcón-Segovia D; Sanchez-Guerrero J
J Rheumatol; 1989 Apr; 16(4):482-8. PubMed ID: 2746588
[TBL] [Abstract][Full Text] [Related]
16. The "primary" antiphospholipid syndrome: major clinical and serological features.
Asherson RA; Khamashta MA; Ordi-Ros J; Derksen RH; Machin SJ; Barquinero J; Outt HH; Harris EN; Vilardell-Torres M; Hughes GR
Medicine (Baltimore); 1989 Nov; 68(6):366-74. PubMed ID: 2509856
[TBL] [Abstract][Full Text] [Related]
17. Arterial/venous thrombosis, fetal loss and stillbirth in pregnant women with systemic lupus erythematosus versus primary and secondary antiphospholipid syndrome: a systematic review and meta-analysis.
Bundhun PK; Soogund MZS; Huang F
BMC Pregnancy Childbirth; 2018 Jun; 18(1):212. PubMed ID: 29879927
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestations of the antiphospholipid syndrome.
Alarcón-Segovia D
J Rheumatol; 1992 Nov; 19(11):1778-81. PubMed ID: 1491400
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid antibodies in the connective tissue diseases: their relation to the antiphospholipid syndrome and forme fruste disease.
Buchanan RR; Wardlaw JR; Riglar AG; Littlejohn GO; Miller MH
J Rheumatol; 1989 Jun; 16(6):757-61. PubMed ID: 2778757
[TBL] [Abstract][Full Text] [Related]
20. [Antiphospholipid antibodies in a series of 25 cases of lupus without antinuclear antibodies. Comparison with a series of 91 lupus patients with antinuclear antibodies].
Meyer O; Piette JC; Bourgeois P; Fallas P; Blétry O; Jungers P; Kahn MF; Godeau P; Ryckewaert A
Ann Med Interne (Paris); 1987; 138(4):256-62. PubMed ID: 3498423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
